血小板衍生微囊泡:创伤性凝血病的潜在疗法
创伤患者常发生低凝状态即创伤性凝血病(TIC),治疗选择有限,新鲜血小板输注效果不够理想且存在多种局限。本文综述文献,提出基于血小板衍生微囊泡(PMVs)的替代疗法;PMVs为细胞外膜包裹、内含细胞质成分的细胞碎片。大量研究已证实PMVs的高凝作用并与血栓相关疾病相关。综述目的是总结PMVs现有认识,并讨论输注分离的人PMVs能否作为TIC的治疗。
要点
- 创伤性凝血病(TIC)治疗选择有限,新鲜血小板输注效果不够理想且存在多种局限。
- 作者提出基于血小板衍生微囊泡(PMVs)的输注可能作为TIC的替代疗法。
- 大量研究已证实PMVs具有高凝作用,并与血栓相关疾病相关。
- PMVs是细胞外膜包裹、内含细胞质成分的细胞碎片。
- 综述旨在总结PMVs现有认识并讨论输注分离人PMVs治疗TIC的可能性。
适用人群与场景
- 创伤患者,常发生低凝状态即创伤性凝血病(TIC)。
处置流程与药物剂量
- 新鲜血小板输注是TIC可用治疗之一,但效果不够理想且存在多种局限。
- 作者提出基于血小板衍生微囊泡(PMVs)的输注可能作为TIC的替代疗法,讨论输注分离的人PMVs用于TIC治疗的可能性。
研究设计与关键结果
- 本文为综述,总结PMVs现有认识并讨论输注分离人PMVs作为TIC治疗的可能性;大量研究已证实PMVs的高凝作用并与血栓相关疾病相关。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者提出输注分离的人PMVs可能作为TIC的替代疗法,该概念基于大量证实PMVs高凝作用并与血栓相关疾病相关的研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Trauma patients are often affected by a hypocoagulable condition referred to as trauma-induced coagulopathy (TIC) for which few therapeutic options exist. One available treatment is fresh platelets transfusion, although it is not efficacious enough and has a number of limitations. Therefore, we reviewed the literature to propose an alternative therapy based on platelet-derived microvesicles (PMVs), which are cellular fragments surrounded by extracellular membrane and filled with cytoplasmic content. This concept is supported by a large number of studies in which the hypercoagulable role of PMVs has been demonstrated and associated with thrombosis-related conditions. The purpose of this review is to summarize what is currently known about PMVs and discuss whether a transfusion of isolated human PMVs could be used as a therapy for TIC.
参考来源
- Lopez E, Srivastava AK, Pati S, et al. Platelet-Derived Microvesicles: A Potential Therapy for Trauma-Induced Coagulopathy. Shock. 2018. PMID: 28858139. doi:10.1097/SHK.0000000000000974
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。